Because tirzepatide and semaglutide have different receptor profiles, half-lives, and dose-response curves, there is no direct milligram-to-milligram conversion
Mounjaro is administered once weekly via subcutaneous injection, offering convenience and effectiveness for patients with type 2 diabetes
Semaglutide is an injectable medication originally developed for type 2 diabetes, now FDA-approved for chronic weight management
Discard it immediately Consult the pharmacy or healthcare provider for a replacement
Pharmacological treatments can help, yet they're not universally effective and may present significant pill burden
compounded liquid (pre-mixed) Some compounding pharmacies provide semaglutide as a pre-mixed liquid in multi-dose vials, typically at concentrations like 2.5 mg/mL or 5 mg/mL